| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/11/2008 | CN101198321A Hematopoietic factor production promoter |
| 06/11/2008 | CN101195604A 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity |
| 06/11/2008 | CN101195026A Lactase granular formulation and method for preparing the same |
| 06/11/2008 | CN101195004A Superpolymer high-activity cerebral flexure enzyme traditional Chinese medicine preparation series for removing blood stasis |
| 06/11/2008 | CN101194794A Medicine pillow for foot health care |
| 06/11/2008 | CN101194720A Medicinal food for air make-up and blood-nourishing |
| 06/11/2008 | CN100393722C Inhibitors of nucleoside metabolism |
| 06/11/2008 | CN100393719C Process for preparing an anticholinergic |
| 06/11/2008 | CN100393715C Imidazole deriviatives and their use as peripherally-selective inhibitors of dopamine-beta-hydroxylase |
| 06/11/2008 | CN100393703C 1,2,3,4-tetrahydroisoquinoline derivatives |
| 06/11/2008 | CN100393354C Traditional Chinese medicine for treating postoperative abdominal distention of pelvic cavity viscera |
| 06/11/2008 | CN100393352C Local external application medicine for treating appendicitis and preparing method |
| 06/11/2008 | CN100393328C Traditional Chinese medicine composition for restoring consciousness and expelling worms and preventing moth, and the fragrant bag containing same |
| 06/11/2008 | CN100393317C Polyene phosphatidyl choline infusion solution and its preparing method |
| 06/10/2008 | US7385083 Calcium-activated potassium channel (BK channel) with opening activity equivalent to or higher than that of maxikdiol, and has high specificity |
| 06/10/2008 | US7385063 Method for preparing imidazole derivatives |
| 06/10/2008 | US7385035 Cytotoxic protein and utilization thereof |
| 06/10/2008 | US7385032 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 06/10/2008 | US7385026 Modified ghrelin polypeptides |
| 06/10/2008 | US7385024 For therapy of proliferative diseases (particularly cancer), acromegaly or diabetic nephropathies and retinopathies |
| 06/10/2008 | US7384983 R-(-)-N-methyl 3-((2-methyl-4-hydroxyphenyl)oxy)-3-phenyl-1-aminopropane or its hydrochloride salt; inhibiting the uptake of norepinephrine and serotonin; antidepressants, analgesics; treating sleep disorders, autism, psychological disorders, eating disorders |
| 06/10/2008 | US7384981 Preparation for improving the action of receptors |
| 06/10/2008 | US7384980 Derivatives of 3,3-diphenylpropylamines |
| 06/10/2008 | US7384976 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 06/10/2008 | US7384973 Materials and methods for treating hypercholesterolemia |
| 06/10/2008 | US7384967 Aryl carbonyl derivatives as therapeutic agents |
| 06/10/2008 | US7384963 2′-Methyl-5-(1,3,4-oxadiazol-2-yl)1, 1′-biphenyl-4-carboxaide derivatives and their use as p38 kinase |
| 06/10/2008 | US7384960 Cannabinoid CB1 receptor antagonists; e.g. substituted 1,5-dihydroisothiochromeno[4,3-c]pyrazole-3-carboxamide compounds; schizophrenia, memory, appetite disorders |
| 06/10/2008 | US7384958 Quinoline inhibitors of cGMP phosphodiesterase |
| 06/10/2008 | US7384957 3,4-dihydro-1H-isoquinolin-2-yl-derivatives |
| 06/10/2008 | US7384950 Respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 06/10/2008 | US7384948 Graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides |
| 06/10/2008 | US7384942 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/10/2008 | US7384940 Calibration kinase resistance; anticancer agents |
| 06/10/2008 | US7384925 2' Hydroxy-3'-bromo-3,4,4',5-tetramethoxy-(Z)-stilbene; antimitotic agent; inhibits the assembly of tubulin into microtubules; anticarcinogenic: solid tumor cancers, neovascularization; tubulin-binding stilbenoid analogs structurally related to combretastatin A-1 and A-4 (extract from willow tree) |
| 06/10/2008 | US7384917 oligopeptides having renin suppression, diuretic and/or vasodilator activity in mammals; treating congestive heart failure |
| 06/10/2008 | US7384912 Administering parathyroid hormone-related protein intermittently at a dosage of at least 500 mu g/day for at least one month,to increase bone mass densityat a rate of at least 1% per month; treating osteoporosis |
| 06/10/2008 | US7384756 Methods for treating muscle diseases and disorders |
| 06/10/2008 | US7384627 Antitumor agents with the use of HSV |
| 06/10/2008 | US7384418 Methods and devices for delivery of agents to breast milk ducts |
| 06/10/2008 | US7383970 Valve with a two-component seal |
| 06/10/2008 | CA2431068C Crystalline forms of atorvastatin |
| 06/10/2008 | CA2427338C Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 06/10/2008 | CA2365826C Over-coated chewing gum formulations |
| 06/10/2008 | CA2345121C Pharmaceutical composition for the treatment of acute disorders |
| 06/10/2008 | CA2325933C Fatty acid derivatives of bile acids and bile acid derivatives |
| 06/10/2008 | CA2310028C High drug load immediate and modified release oral dosage formulations and processes for their manufacture |
| 06/10/2008 | CA2296665C Triazolo[4,5-d]pyrimidine derivatives as anti-thromobotic agents |
| 06/10/2008 | CA2153756C Transport protein which effects the transport of cationic xenobiotics and/or pharmaceuticals, dna sequences encoding it and their use |
| 06/05/2008 | WO2008067549A2 Stabilized zolpidem pharmaceutical compositions |
| 06/05/2008 | WO2008067145A2 Self-assembling peptide amphiphiles |
| 06/05/2008 | WO2008067049A2 Particles for cell targeting |
| 06/05/2008 | WO2008066750A1 Methods of treating mental retardation, down's syndrome, fragile x syndrome and autism |
| 06/05/2008 | WO2008066715A2 Method of treatment using aspergillus oryzae protease |
| 06/05/2008 | WO2008066403A1 Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method |
| 06/05/2008 | WO2008066151A1 Novel curcumin derivative |
| 06/05/2008 | WO2008066145A1 Thiazole derivative and use thereof as vap-1 inhibitor |
| 06/05/2008 | WO2008066131A1 Novel phenyl-isoxazol-3-ol derivative |
| 06/05/2008 | WO2008066097A1 Carboxylic acid derivative |
| 06/05/2008 | WO2008066070A1 Dipeptidyl peptidase-iv inhibitor |
| 06/05/2008 | WO2008066032A1 Lymphangiogenesis inhibitory factor |
| 06/05/2008 | WO2008065796A1 α-GLUCOSIDASE INHIBITOR |
| 06/05/2008 | WO2008065754A1 Substituted carbinol compound |
| 06/05/2008 | WO2008065752A1 Immunotherapeutic agent containing dirna as active ingredient |
| 06/05/2008 | WO2008065726A1 Telomelysin-containing agent for breaking antitumor tolerance |
| 06/05/2008 | WO2008065666A2 Uses of incensole, incensole acetate and derivatives thereof |
| 06/05/2008 | WO2008043075A3 Compositions for the treatment of scleritis |
| 06/05/2008 | WO2008005295A3 Modulators of muscarinic receptors |
| 06/05/2008 | WO2007018431A3 Triazole-containing releasable linkers and conjugates comprising the same |
| 06/05/2008 | US20080132706 Compounds as PDE IV and TNF Inhibitors |
| 06/05/2008 | US20080132704 3-Substituted quinuclidines and their use |
| 06/05/2008 | US20080132678 Such as N-(4-morpholine)carbonyl-(O-benzyl)-L-tyrosine-L-leucine boronic acid for reducing rate of degradation of proteins; proteasome inhibitors |
| 06/05/2008 | US20080132581 particularly tyrosinase; preventing and treating melanin overproduction; isolated from a plant family selected from the group consisting of Compositae, Fabaceae, Lauraceae, Leguminosae, Liliaceae, Loranthaceae, Moracea, and Myristicaceae |
| 06/05/2008 | US20080132578 venlafaxine metabolites used for treating and preventing psychological disorders, Parkinson's disease, epilepsy, obesity, incontinence or Alzheimer's disease; side effect reduction |
| 06/05/2008 | US20080132577 N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide its hydrates, crystalline forms and addition salts; agonist of receptors of the melatoninergic system and an antagonist of the 5-HT2C receptor; treats genetic disorder characterized by a specific pattern of physical, behavioral, and developmetnal features |
| 06/05/2008 | US20080132574 Leukotriene B4 receptor binding activity; treatment of skin disease such as psoriasis, eczema, skin cancer, keratosis, dyspigmentation or psilosis |
| 06/05/2008 | US20080132561 Materials and Methods for Treating Hypercholesterolemia |
| 06/05/2008 | US20080132556 3-hydroxymethyl-4hydroxy-phenyl- derivatives for the treatment of respiratory diseases |
| 06/05/2008 | US20080132546 e.g. Methyl 2-(6-{[(ethylamino)carbonyl]amino}pyridin-3-yl)-1,3-thiazole-5-carboxylate; bacterial DNA gyrase or bacterial topoisomerase IV inhibitor; antibacterial agent; antibiotic resistance; skin structure infections, pneumoniae, bronchitis, acute sinusitis, otitis media, sepsis, osteomyelitis |
| 06/05/2008 | US20080132539 e.g. 2-amino-5-[(naphthalen-1-ylmethyl)-aminocarbonyl]-pentanoic acid hydroxyamide; advanced glycosylation endproducts inhibitor; diabetic neurosis, diabetic retinopathy, atherosclerosis, cataract, Alzheimer's disease, rheumatic arthritis, osteoarthritis, chronic renal failure; food and cosmetics |
| 06/05/2008 | US20080132535 for buccal delivery; carbonate and bicarbonate buffer system in an amount sufficient to raise the pH of saliva to at least 8.5 irrespective of starting pH; treating middle-of-the-night insomnia |
| 06/05/2008 | US20080132532 dosage strength of the second dosage form is greater than that of the first dosage form; kits |
| 06/05/2008 | US20080132517 Method of enhancing absorptions of transmucosal administration formulations |
| 06/05/2008 | US20080132490 1-heteroaryl-4-benzoyl-5-(alkyl or cycloalkyl)-1,4-diazepanes; sleep disorders, analgesics, obesity, Parkinson's disease, psychosis and schizophrenia; 6-fluoro-2-{(5R)-5-methyl-4-[2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl}quinazoline for example |
| 06/05/2008 | US20080132483 Administering (3R,5S)-N-propanesulfonyl-7-chloro-5-(2,3-dimethoxyphenyl)-1-(3-hydroxy-2,2-dimethylpropyl)-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetamide; cerebral infarction |
| 06/05/2008 | US20080132481 Use of 3-substituted amino-2-carboxy-substituted indoles or benzo(b)thiophenes or esters thereof that modulate T helper (Th) cells; treating allergy, asthma, rhinitis, dermatitis, B-cell lymphomas, tumors and diseases associated with bacterial, rhinovirus or respiratory syncytial virus (RSV) infections |
| 06/05/2008 | US20080132467 Polysaccharide of chitosan or chitin, and an energy converter activated by non-UV light, film or gel insoluble in water and physiological fluids; reduced risk of causing thermal damage to tissue. |
| 06/05/2008 | US20080132463 Pharmaceutical use of alpha antigen or alpha antigen gene |
| 06/05/2008 | US20080132461 Introducing RNA which targets the mRNA of the gene for degradation into the cell or organism; maintaining the cell or organism, maintaining the cell or organism under conditions under which degradation of the mRNA occurs |
| 06/05/2008 | US20080132460 Screening for a compound which inhibits p62/ubiquitin binding; detecting the formation of inclusion bodies in neurodegenerative diseases; screening for therapeutic agents that disperse the inclusions |
| 06/05/2008 | US20080132453 amino acid sequence: One example is Nal-Tyr-cyclo(D-Cys-D-Trp-Lys-D-Cys)-Abu-Nal-NH2; lung cancer, glioma, anorexia, hypothyroidism; various D-amino acid-substituted and constrained amino acid-substituted cyclo somatostatin analogs that function as potent mu opioid receptor antagonists |
| 06/05/2008 | US20080132448 Conserved neisserial antigens |
| 06/05/2008 | US20080132445 increasing milk production; inhibiting tumors; administering Galanin with prolactin; transgenic mammal |
| 06/05/2008 | US20080131931 Expression vector comprising nucleotide sequences coding protein which binds interleukin-10 related t cell-derived inducible factor (IL-TIF); for use in targeting cell for surgical removal |
| 06/05/2008 | US20080131889 Novel human genes and gene expression products: II |
| 06/05/2008 | US20080131884 Tubulin Mutation Diagnostic |
| 06/05/2008 | US20080131565 Edible composition; partially defatted cocoa solids prepared by heating slaty and/or purple cocoa beans, winnowing the cocoa nibs from the cocoa shells; pressing the cocoa nibs to produce cocoa butter, recovering the cocoa butter and solids; adding the recovered, defatted cocoa solids |
| 06/05/2008 | US20080131523 Composition and therapeutic uses thereof |
| 06/05/2008 | US20080131516 Granule formation |
| 06/05/2008 | US20080131511 Use of(-)-S isomer of 2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4.5]decane or salt thereof (YM-796) to accelerate tear and salivary fluid secretion without accompanying sweating; sustained release with a hydrophilic base and a polymeric hydrogel as carrier |